Novartis AG Issued Capital
Novartis AG (NVS) had Issued Capital of $766.00 million as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:IssuedCapital · last filed 2026-02-04
- 2025-12-31: Issued Capital $766.00M.
- 2025-06-30: Issued Capital $766.00M.
- 2024-12-31: Issued Capital $793.00M.
- 2024-06-30: Issued Capital $793.00M.
| Period end | Issued Capital |
|---|---|
| 2025-12-31 | $766.00M 20-F · filed 2026-02-04 |
| 2025-06-30 | $766.00M 6-K · filed 2025-07-17 |
| 2024-12-31 | $793.00M 20-F · filed 2026-02-04 |
| 2024-06-30 | $793.00M 6-K · filed 2024-07-18 |
| 2023-12-31 | $825.00M 20-F · filed 2026-02-04 |
| 2023-06-30 | $842.00M 6-K · filed 2023-07-18 |
| 2022-12-31 | $890.00M 20-F · filed 2026-02-04 |
| 2022-06-30 | $890.00M 6-K · filed 2022-07-19 |
| 2021-12-31 | $901.00M 20-F · filed 2025-01-31 |
| 2021-06-30 | $913.00M 6-K · filed 2021-07-21 |
| 2020-12-31 | $913.00M 20-F · filed 2024-01-31 |
| 2020-06-30 | $913.00M 6-K · filed 2020-07-21 |
| 2019-12-31 | $936.00M 20-F/A · filed 2023-05-15 |
| 2019-06-30 | $936.00M 6-K · filed 2019-07-18 |
| 2018-12-31 | $944.00M 20-F · filed 2022-02-02 |
| 2018-06-30 | $944.00M 6-K · filed 2018-07-18 |
| 2017-12-31 | $969.00M 20-F · filed 2021-01-26 |
| 2016-12-31 | $972.00M 20-F · filed 2020-01-29 |
| 2015-12-31 | $991.00M 20-F · filed 2019-01-30 |
| 2014-12-31 | $1.00B 6-K · filed 2018-01-24 |